Emerging evidence for adapting radiotherapy to immunotherapy

L Galluzzi, MJ Aryankalayil, CN Coleman… - Nature reviews Clinical …, 2023‏ - nature.com
Immunotherapy has revolutionized the clinical management of many malignancies but is
infrequently associated with durable objective responses when used as a standalone …

A review of proton therapy–Current status and future directions

R Mohan - Precision radiation oncology, 2022‏ - Wiley Online Library
The original rationale for proton therapy was its highly conformal depth‐dose distributions
compared to photons, which allow greater sparing of normal tissues and escalation of tumor …

Ultra-high dose rate (FLASH) radiotherapy: Silver bullet or fool's gold?

JD Wilson, EM Hammond, GS Higgins… - Frontiers in …, 2020‏ - frontiersin.org
Radiotherapy is a cornerstone of both curative and palliative cancer care. However,
radiotherapy is severely limited by radiation-induced toxicities. If these toxicities could be …

Current state of immunotherapy for glioblastoma

M Lim, Y **a, C Bettegowda, M Weller - Nature reviews Clinical …, 2018‏ - nature.com
Glioma is the most common primary cancer of the central nervous system, and around 50%
of patients present with the most aggressive form of the disease, glioblastoma. Conventional …

Radiobiology of the FLASH effect

AA Friedl, KM Prise, KT Butterworth… - Medical …, 2022‏ - Wiley Online Library
Radiation exposures at ultrahigh dose rates (UHDRs) at several orders of magnitude greater
than in current clinical radiotherapy (RT) have been shown to manifest differential …

Radiation-induced circulating myeloid-derived suppressor cells induce systemic lymphopenia after chemoradiotherapy in patients with glioblastoma

S Ghosh, J Huang, M Inkman, J Zhang… - Science translational …, 2023‏ - science.org
Severe and prolonged lymphopenia frequently occurs in patients with glioblastoma after
standard chemoradiotherapy and has been associated with worse survival, but its …

A review on lymphocyte radiosensitivity and its impact on radiotherapy

H Paganetti - Frontiers in Oncology, 2023‏ - frontiersin.org
It is well known that radiation therapy causes lymphopenia in patients and that this is
correlated with a negative outcome. The mechanism is not well understood because …

Charged-particle therapy in cancer: clinical uses and future perspectives

M Durante, R Orecchia, JS Loeffler - Nature Reviews Clinical Oncology, 2017‏ - nature.com
Radiotherapy with high-energy charged particles has become an attractive therapeutic
option for patients with several tumour types because this approach better spares healthy …

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma

X Wang, G Guo, H Guan, Y Yu, J Lu, J Yu - Journal of Experimental & …, 2019‏ - Springer
Abstract PD-1/PD-L1 checkpoint blockades have achieved significant progress in several
kinds of tumours. Pembrolizumab, which targets PD-1, has been approved as a first-line …

CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges

SJ Bagley, AS Desai, GP Linette, CH June… - Neuro …, 2018‏ - academic.oup.com
In patients with certain hematologic malignancies, the use of autologous T cells genetically
modified to express chimeric antigen receptors (CARs) has led to unprecedented clinical …